Skip to main content

Tufts Medical Center Atrium 3 Pharmacy

Articles
New HHS Peptide Policy: What Patients Should Know
November 2, 2026
A new HHS policy addresses compounding certain peptides. Learn what it means for FDA approval, safety and patients considering peptide therapy.
In the News
Biosimilar Uptake Has Been Slow but This is Changing
June 13, 2025
James Chambers, PhD, MPharm, MSc, Investigator in the Center for the Evaluation of Value and Risk in Health at the Institute for Clinical Research and Health Policy Studies at Tufts Medical Center, about the increasing confidence of healthcare payers in biosimilars.
In the News
The Banking of Biosimilars: Insights From a Leading Health Economist
February 4, 2025
James Chambers, PhD, MPharm, MSc, Investigator in the Center for the Evaluation of Value and Risk in Health at the Institute for Clinical Research and Health Policy Studies at Tufts Medical Center, about the economic and policy-related factors that influence the adoption and impact of biosimilars.

Keeping You Connected

Healthy Reads is Tufts Medicine’s monthly email newsletter—bringing you the latest health tips, inspiring patient stories and groundbreaking research. Sign up today and get the health news you need delivered right to your inbox.

Jump back to top